• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 cluster4x 对数据集进行预聚类可以提高高通量晶体学药物筛选分析的信噪比。

Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis.

机构信息

Diamond Light Source Ltd, Didcot OX11 0DE, United Kingdom.

出版信息

Acta Crystallogr D Struct Biol. 2020 Nov 1;76(Pt 11):1134-1144. doi: 10.1107/S2059798320012619. Epub 2020 Oct 16.

DOI:10.1107/S2059798320012619
PMID:33135684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7604910/
Abstract

Drug and fragment screening at X-ray crystallography beamlines has been a huge success. However, it is inevitable that more high-profile biological drug targets will be identified for which high-quality, highly homogenous crystal systems cannot be found. With increasing heterogeneity in crystal systems, the application of current multi-data-set methods becomes ever less sensitive to bound ligands. In order to ease the bottleneck of finding a well behaved crystal system, pre-clustering of data sets can be carried out using cluster4x after data collection to separate data sets into smaller partitions in order to restore the sensitivity of multi-data-set methods. Here, the software cluster4x is introduced for this purpose and validated against published data sets using PanDDA, showing an improved total signal from existing ligands and identifying new hits in both highly heterogenous and less heterogenous multi-data sets. cluster4x provides the researcher with an interactive graphical user interface with which to explore multi-data set experiments.

摘要

药物和片段筛选在 X 射线晶体学光束线上已经取得了巨大的成功。然而,不可避免的是,将会有更多备受关注的生物药物靶点被确定,而这些靶点无法找到高质量、高度同质的晶体系统。随着晶体系统的异质性增加,当前多数据集方法的应用对结合配体的灵敏度越来越低。为了缓解找到良好晶体系统的瓶颈问题,可以在数据收集后使用 cluster4x 对数据集进行预聚类,将数据集分成更小的分区,以恢复多数据集方法的灵敏度。这里,引入了软件 cluster4x 来达到这个目的,并使用 PanDDA 对已发布的数据集进行验证,显示出从现有配体中获得的总信号得到了改善,并在高度异质和异质程度较低的多数据集都识别到了新的命中。cluster4x 为研究人员提供了一个带有交互图形用户界面的工具,可以用于探索多数据集实验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/966864762839/d-76-01134-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/d968f9a525a3/d-76-01134-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/8ed575e038c2/d-76-01134-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/77a64591e7e2/d-76-01134-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/db7f78c21b89/d-76-01134-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/966864762839/d-76-01134-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/d968f9a525a3/d-76-01134-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/8ed575e038c2/d-76-01134-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/77a64591e7e2/d-76-01134-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/db7f78c21b89/d-76-01134-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf8f/7604910/966864762839/d-76-01134-fig5.jpg

相似文献

1
Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis.使用 cluster4x 对数据集进行预聚类可以提高高通量晶体学药物筛选分析的信噪比。
Acta Crystallogr D Struct Biol. 2020 Nov 1;76(Pt 11):1134-1144. doi: 10.1107/S2059798320012619. Epub 2020 Oct 16.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Predicting the success of fragment screening by X-ray crystallography.通过X射线晶体学预测片段筛选的成功率。
Methods Enzymol. 2011;493:91-114. doi: 10.1016/B978-0-12-381274-2.00004-2.
4
Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery.晶体学片段筛选的优势:来自高效药物发现强大平台的功能和机制见解。
Prog Biophys Mol Biol. 2014 Nov-Dec;116(2-3):92-100. doi: 10.1016/j.pbiomolbio.2014.08.004. Epub 2014 Aug 10.
5
HEIDI: an experiment-management platform enabling high-throughput fragment and compound screening.HEIDI:一个支持高通量片段和化合物筛选的实验管理平台。
Acta Crystallogr D Struct Biol. 2024 May 1;80(Pt 5):328-335. doi: 10.1107/S2059798324002833. Epub 2024 Apr 12.
6
Fragment screening purely with protein crystallography.仅通过蛋白质晶体学进行片段筛选。
Methods Enzymol. 2011;493:321-56. doi: 10.1016/B978-0-12-381274-2.00013-3.
7
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin.在柏林亥姆霍兹中心的晶体筛选工作流程和工具。
J Vis Exp. 2021 Mar 3(169). doi: 10.3791/62208.
8
Fragment-based screening using X-ray crystallography and NMR spectroscopy.使用X射线晶体学和核磁共振光谱法的基于片段的筛选。
Curr Opin Chem Biol. 2007 Oct;11(5):485-93. doi: 10.1016/j.cbpa.2007.07.010. Epub 2007 Sep 11.
9
Diffraction cartography: applying microbeams to macromolecular crystallography sample evaluation and data collection.衍射成像技术:将微束应用于大分子晶体学样品评估和数据收集。
Acta Crystallogr D Biol Crystallogr. 2010 Aug;66(Pt 8):855-64. doi: 10.1107/S0907444910019591. Epub 2010 Jul 9.
10
Fast fragment and compound screening pipeline at the Swiss Light Source.瑞士光源的快速片段和化合物筛选流水线。
Methods Enzymol. 2023;690:235-284. doi: 10.1016/bs.mie.2023.08.005. Epub 2023 Sep 12.

引用本文的文献

1
Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals.登革病毒聚合酶的晶体学片段筛选揭示了用于开发非核苷类抗黄病毒药物的多个结合位点。
J Med Chem. 2025 Sep 11;68(17):18356-18369. doi: 10.1021/acs.jmedchem.5c01014. Epub 2025 Sep 2.
2
Orchestrating function: Concerted dynamics, allostery, and catalysis in protein tyrosine phosphatases.协调功能:蛋白酪氨酸磷酸酶中的协同动力学、别构效应与催化作用
Curr Opin Struct Biol. 2025 Aug 1;94:103125. doi: 10.1016/j.sbi.2025.103125.
3
Enhanced intensity-based clustering of isomorphous multi-crystal data sets in the presence of subtle variations.

本文引用的文献

1
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶的晶体学和亲电片段筛选。
Nat Commun. 2020 Oct 7;11(1):5047. doi: 10.1038/s41467-020-18709-w.
2
F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.F2X-Universal 和 F2X-Entry:用于晶体筛选的结构多样的化合物库。
Structure. 2020 Jun 2;28(6):694-706.e5. doi: 10.1016/j.str.2020.04.019. Epub 2020 May 14.
3
A Proof-of-Concept Fragment Screening of a Hit-Validated 96-Compounds Library against Human Carbonic Anhydrase II.
在存在细微变化的情况下,对同构多晶体数据集进行基于强度增强的聚类。
Acta Crystallogr D Struct Biol. 2025 Jun 1;81(Pt 6):278-290. doi: 10.1107/S2059798325004589. Epub 2025 May 29.
4
Where and how to house big data on small fragments.在小片段上存储大数据的位置及方式。
Nat Commun. 2025 May 5;16(1):4179. doi: 10.1038/s41467-025-59233-z.
5
Mapping Protein Conformational Landscapes from Crystallographic Drug Fragment Screens.从晶体学药物片段筛选中绘制蛋白质构象景观图。
J Chem Inf Model. 2024 Dec 9;64(23):8937-8951. doi: 10.1021/acs.jcim.4c01380. Epub 2024 Nov 12.
6
Mapping protein conformational landscapes from crystallographic drug fragment screens.从晶体学药物片段筛选中绘制蛋白质构象图谱。
bioRxiv. 2024 Jul 30:2024.07.29.605395. doi: 10.1101/2024.07.29.605395.
7
An expanded trove of fragment-bound structures for the allosteric enzyme PTP1B from computational reanalysis of large-scale crystallographic data.通过对大规模晶体学数据的重新计算分析,获得了变构酶 PTP1B 的更多片段结合结构。
Structure. 2024 Aug 8;32(8):1231-1238.e4. doi: 10.1016/j.str.2024.05.010. Epub 2024 Jun 10.
8
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.一项结构-功能分析表明,SARS-CoV-2 BA.2.86 平衡了抗体逃逸和 ACE2 亲和力。
Cell Rep Med. 2024 May 21;5(5):101553. doi: 10.1016/j.xcrm.2024.101553. Epub 2024 May 8.
9
An expanded view of ligandability in the allosteric enzyme PTP1B from computational reanalysis of large-scale crystallographic data.通过对大规模晶体学数据的计算重新分析,对变构酶蛋白酪氨酸磷酸酶1B(PTP1B)中可配体性的扩展认识。
bioRxiv. 2024 Jan 7:2024.01.05.574428. doi: 10.1101/2024.01.05.574428.
10
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease.SARS-CoV-2 NSP15 内切核酸酶的变构调节和晶体学片段筛选。
Nucleic Acids Res. 2023 Jun 9;51(10):5255-5270. doi: 10.1093/nar/gkad314.
针对人碳酸酐酶 II 的验证命中化合物库的概念验证片段筛选。
Biomolecules. 2020 Mar 29;10(4):518. doi: 10.3390/biom10040518.
4
A shared vision for macromolecular crystallography over the next five years.未来五年大分子晶体学的共同愿景。
Struct Dyn. 2019 Dec 4;6(6):064302. doi: 10.1063/1.5131017. eCollection 2019 Nov.
5
Achieving a Good Crystal System for Crystallographic X-Ray Fragment Screening.为晶体学X射线片段筛选获得良好的晶体系统。
Methods Enzymol. 2018;610:251-264. doi: 10.1016/bs.mie.2018.09.027. Epub 2018 Oct 15.
6
An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.通过多温度晶体学、片段筛选和共价连接,在 PTP1B 中扩展的变构网络。
Elife. 2018 Jun 7;7:e36307. doi: 10.7554/eLife.36307.
7
Determination of Patterson group symmetry from sparse multi-crystal data sets in the presence of an indexing ambiguity.在存在索引歧义的情况下,从稀疏多晶体数据集确定 Patterson 群对称性。
Acta Crystallogr D Struct Biol. 2018 May 1;74(Pt 5):405-410. doi: 10.1107/S2059798318002978. Epub 2018 Apr 24.
8
Where is crystallography going?晶体学的未来走向如何?
Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):152-166. doi: 10.1107/S2059798317016709.
9
Dissecting random and systematic differences between noisy composite data sets.剖析噪声复合数据集之间的随机和系统差异。
Acta Crystallogr D Struct Biol. 2017 Apr 1;73(Pt 4):286-293. doi: 10.1107/S2059798317000699. Epub 2017 Mar 31.
10
High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits.高通量晶体学:可靠高效的片段命中鉴定。
Structure. 2016 Aug 2;24(8):1398-1409. doi: 10.1016/j.str.2016.06.010. Epub 2016 Jul 21.